Healthcare | August 03, 2021
Healthium Medtech acquires SGK Lab’s AbGel gelatin business
Complementary business models are the reason for the acquisition
Complementary business models are the reason for the acquisition
This deal makes Meddo, one of the largest health-tech players in India
The govt has rolled out three schemes for promoting the manufacture of API
Drug formulations and biologics make impressive gains
Turnover of API division of ISLL stood at Rs 856.58 crore
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
India business is growing as per projections; whereas US business will bounce back soon.
Proceeds from the IPO will be used for the expansion of the Dehradun facility.
Price band in the range of Rs 933 to Rs 954
It posted net profit of Rs.147.76 crores for the period ended June 30, 2020.
Subscribe To Our Newsletter & Stay Updated
